期刊文献+

磁共振成像在宫颈癌临床分期中的应用价值 被引量:15

Applied Value of Magnetic Resonance Imaging in the Clinical Stage of Cervical Cancer
原文传递
导出
摘要 目的探讨磁共振成像(MRI)在宫颈癌临床分期中的应用价值。方法收集2009年9月至2011年9月本院收治的临床资料完整的宫颈癌患者92例为研究对象,年龄为29~82岁,分析其术前MRI影像特点,对比其中73例行选择性广泛性子宫切除术+盆腔淋巴结清扫术患者的术后病理学检查结果(本研究遵循的程序符合大连医科大学附属第一医院人体试验委员会制定的伦理学标准,得到该委员会批准)。结果 MRI检查显示,除2例ⅠA期患者外,90例异常宫颈均有提示,检出率为97.8%(90/92),T1WI多呈低或等低信号,T2WI为高信号,增强后81例表现不同程度强化,DWI上均呈高信号影,49例宫颈基质环显示不完整、43例显示完整,盆腔淋巴结增大显示为21例。MRI与临床分期总体一致性为85.9%,对宫旁浸润、累及阴道、淋巴结转移、累及颈管阴性预测值分别为95.3%,98.2%,93.1%,78.3%;特异度分别为93.8%,83.6%,84.4%,90.4%;灵敏度分别为62.5%,83.3%,55.6%,38.1%。结论 MRI能清楚显示宫颈癌病灶大小、宫旁、阴道、颈管受累程度及增大的盆腔淋巴结,在宫颈癌临床分期诊断上具有明显指导价值,可作为宫颈癌特别是浸润性宫颈癌的首选检查方法。 Objective To evaluate applied value of magnetic resonance imaging ( MRI ) in the clinical stage of cervical cancer.Methods From September 2009to September 2011,a total of 92cases ( 29-to 82year-old ) of cervical cancer with completely clinical data were included into this study.The results of MRI before surgery were analyzed.Among those 92cases,73of them received selective radical hysterectomy+ pelvic lymph node dissection.The pathological and MRI results were compared.Informed consent was obtained from all participates.Results MRI could show the cervical cancer in all cases with the exception of only 2cases ofⅠAstage.Positive rate was 97.8% ( 90 / 92 ) .The tumor was represented by isointensity and hypo intensity on T1-weighted MR images and hyper intensity on T2-weighted MR images.After bolus intravenous GD-DTPA injection,varied enhancement presented in 81cases,the tumor was hyper intensity on DWI.The cervical stoma of 49cases showed incompletely,43cases completely.A total of 21cases of enlarged pelvic node were well shown.MRI had an accuracy of 85.9% in clinical stage diagnosis.The negative predictive value of parametrical invasion,vaginal invasion,metastasis of lymph nodes and cervical cannel invasion for MRI were 95.3%,98.2%,93.1%,78.3%,respectively.The specificity were 93.8%,83.6%,84.4%,90.4%,respectively.The sensitivity were 62.5%,83.3%,55.6%,38.1%,respectively. Conclusions MRI can show the location,size,signal characteristics,extension of the primary tumor and parametrical tissue.MRI plays a very useful role in identifying the stages of cervical cancer,especially for invasive carcinoma.MRI can be used as the first choice method for clinical stage of cervical cancer.
出处 《中华妇幼临床医学杂志(电子版)》 CAS 2012年第5期486-490,共5页 Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition)
关键词 宫颈癌 临床分期 肿瘤浸润 磁共振成像 cervical carcinoma clinical stage neoplasm invasiveness magnetic resonance imaging
作者简介 通讯作者王敬民(Email:wjm210204@126.com)
  • 相关文献

参考文献9

  • 1Brocker KA, Ah CD, Eichbaum M, et al. Imaging of female pelvic malignancies regarding MRI, CT, and PET/CT: Part l[J]. Strahlenther Onkol, 2011, 187(10): 611-618.
  • 2Bell DJ, Pannu HK. Radiologieal assessment of gynecologic malignancies[J]. Obstet Gynecol Clin North Am, 2011, 38 (1): 45-68.
  • 3Ozsarlak O, T~alma W, Schepens E, et al. The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma[J]. Eur Radiol, 2003, 13(10): 2338-2345.
  • 4Choi SH, Kim SH, Choi HJ, et al. Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: Results of prospective study[J]. J Comput Assist Tomogr, 2004, 28 (5): 620-627.
  • 5于梅艳,时惠平,李春东,任力,熊明辉,毕永民,田雨.宫颈癌MRI分期与病理对照研究[J].中国误诊学杂志,2011,11(13):3036-3038. 被引量:12
  • 6林开武,张碧清,薛晓玲.宫颈癌的MRI分期与临床及病理分期对照研究[J].医学影像学杂志,2010,20(12):1853-1855. 被引量:35
  • 7Vargas HA, Akin O, Zheng J, et al. The value of MR imaging when the site of uterine cancer origin is uncertain[J].Radiology, 2011, 258(3): 785-792.
  • 8Lin YC, Lin G, Chen YR, et al. Role of magnetic resonance imaging and apparent diffusion coefficient at 3T in distinguishing between adenocarcinoma of the uterine cervix and endometrium [J].ChangGung MedJ, 2011, 34(1): 93-100.
  • 9Bipat S, Glas AS, van der Velden J, etal. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma : A systematic review[J].Gynecol Oncol, 2003, 91 (1) : 989-990.

二级参考文献9

  • 1程玺,蔡树模,李子庭,薛木泉,吴小华,臧荣余.淋巴结转移的Ⅰb1~Ⅱb期子宫颈癌患者手术后的综合治疗及预后分析[J].中华妇产科杂志,2005,40(8):539-543. 被引量:22
  • 2Chung H H, K ang SB, Cho J Y, et a l. Can preoperative MRI accu- rately evaluate nodal and parametrial invasion in early stage cervical cancer[J]. Jpn J Clin Oncol,2007,37(5) :370-375.
  • 3McVeigh PZ, Syed AM, Milosevic M, et al. Diffusion-weighted MRI in cervical caner[J]. European Radiology, 2008, 18 (5) : 1058-1064.
  • 4Narayanan P, Nobbenhuis M, Reynolds KM, et al. Fistulas in malignant gynecologicdisease: etiology, imaging, and management[J]. Radiographics, 2009,29 (4) : 1073-1083.
  • 5Pecorelli S, Zigliani L,Odicino F. Revised FIGO staging for carcinoma of the cervix[J]. Int J Gynaecol Obstet,2009,105(2) 107- 108.
  • 6?. ?zsarlak,W. Tjalma,E. Schepens,B. Corthouts,B. Op Beeck,E. Van Marck,P. M. Parizel,A. M. De Schepper. The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma[J] 2003,European Radiology(10):2338~2345
  • 7M. Shiraiwa,I. Joja,T. Asakawa,K. Okuno,O. Shibutani,N. Akamatsu,T. Kudo,Y. Hiraki. Cervical carcinoma: efficacy of thin-section oblique axial T2-weighted images for evaluating parametrial invasion[J] 1999,Abdominal Imaging(5):514~519
  • 8马丽华,娄阁.MRI指导子宫颈癌分期的临床意义[J].中国妇幼保健,2009,24(28):4021-4023. 被引量:6
  • 9虞登高.MRI在子宫颈癌的诊断与分期中的应用价值[J].实用医学影像杂志,2009,10(5):319-321. 被引量:7

共引文献42

同被引文献111

  • 1宫颈癌及癌前病变规范化诊疗指南(试行)[J].中国医学前沿杂志(电子版),2013,5(8):40-49. 被引量:261
  • 2陈对梅,王峻,牛金亮,郑英.MRI评估宫颈癌宫旁侵犯和淋巴结转移的价值[J].中国医学影像技术,2009,25(S1):138-140. 被引量:14
  • 3林开武,张碧清,薛晓玲.宫颈癌的MRI分期与临床及病理分期对照研究[J].医学影像学杂志,2010,20(12):1853-1855. 被引量:35
  • 4吴红珍,江新青,谢琦.MRI在宫颈癌中的临床应用价值及研究进展[J].国外医学(临床放射学分册),2007,30(5):338-340. 被引量:4
  • 5高克非,刘富元,冯艳玲,等.子宫颈癌盆腔淋巴结转移的术前CT评价[J].临床肿瘤学杂志,2013,24(12):458-462.
  • 6Sung Bin Park, Min Hoan Moon, Chang Kyu Sung, etal. Dynamic Contrast-Enhanced MR Imaging of Endometrial Cancer: Optimizing the Imaging Delay for Tumour-Myometriunl Contrast[J].European Radiology, 2014, 24 (11):2795-2799.
  • 7Liana S vampane, I l ze Strumfa, Dace Berzina, etal. Epidemiological analysis of hereditary endometrial cancer in a large study population[J]. Archives of Gynecology and Obstetrics, 2014, 289 (5):1093-1099.
  • 8Yang Liu, Weihua Li, Xin Li, etal. Expression and significance of biglycan in endometrial cancer[J].Archives of Gynecology and Obstetrics, 2014, 289 (3):649-655.
  • 9Xueying gang, Aihua Feng, Fengying Liu, etal. CgPl7A1 T-34C polymorphism is not associated with endometrial cancerrisk[J]. Tumor Biology, 2013,34 (5):2583- 2587.
  • 10Downey K,Riches SF,Morgan VA,et al. Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features:quantitative histogram analysis of diffusion- weighted MR images[J], AJR Am J Roentgenol,2013,200(2): 314-320.

引证文献15

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部